TREATMENT OF DONOR BONE-MARROW WITH MONOCLONAL ANTI-T-CELL ANTIBODY AND COMPLEMENT FOR THE PREVENTION OF GRAFT-VERSUS-HOST DISEASE - A PROSPECTIVE, RANDOMIZED, DOUBLE-BLIND TRIAL

被引：324
作者：
MITSUYASU, RT
CHAMPLIN, RE
GALE, RP
HO, WG
LENARSKY, C
WINSTON, D
SELCH, M
ELASHOFF, R
GIORGI, JV
WELLS, J
TERASAKI, P
BILLING, R
FEIG, S
机构：
[1] UNIV CALIF LOS ANGELES, SCH MED, TRANSPLANTAT BIOL PROGRAM, LOS ANGELES, CA 90024 USA
[2] UNIV CALIF LOS ANGELES, SCH MED, DEPT PEDIAT, LOS ANGELES, CA 90024 USA
[3] UNIV CALIF LOS ANGELES, SCH MED, DEPT SURG, LOS ANGELES, CA 90024 USA
[4] UNIV CALIF LOS ANGELES, SCH MED, DEPT BIOMATH, LOS ANGELES, CA 90024 USA
[5] UNIV CALIF LOS ANGELES, SCH MED, DEPT RADIAT ONCOL, LOS ANGELES, CA 90024 USA
[6] UNIV CALIF LOS ANGELES, SCH MED, DEPT MICROBIOL & IMMUNOL, LOS ANGELES, CA 90024 USA
[7] UNIV CALIF LOS ANGELES, CTR HLTH SCI, JONSSON COMPREHENS CANC CTR, LOS ANGELES, CA 90024 USA
来源：
ANNALS OF INTERNAL MEDICINE | 1986年 / 105卷 / 01期
关键词：
D O I：
10.7326/0003-4819-105-1-20
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：20 / 26
页数：7
相关论文
共 63 条
[1]  
BORTIN MM, 1985, EXP HEMATOL, V13, P406
[2]  
BOYUM A, 1968, SCAND J CLIN LAB INV, VS 21, P51
[3]  
BUTTURINI A, 1986, J BIOCH SD, V10, P224
[4]  
CHAMPLIN R, 1985, SEMIN ONCOL, V12, P190
[5]  
CHAMPLIN RE, 1984, CANCER TREAT REP, V68, P145
[6]   CYCLOSPORINE AS PROPHYLAXIS FOR GRAFT-VERSUS-HOST DISEASE - A RANDOMIZED STUDY IN PATIENTS UNDERGOING MARROW TRANSPLANTATION FOR ACUTE NONLYMPHOBLASTIC LEUKEMIA [J].
DEEG, HJ ;
STORB, R ;
THOMAS, ED ;
FLOURNOY, N ;
KENNEDY, MS ;
BANAJI, M ;
APPELBAUM, FR ;
BENSINGER, WI ;
BUCKNER, CD ;
CLIFT, RA ;
DONEY, K ;
FEFER, A ;
MCGUFFIN, R ;
SANDERS, JE ;
SINGER, J ;
STEWART, P ;
SULLIVAN, KM ;
WITHERSPOON, RP .
BLOOD, 1985, 65 (06) :1325-1334
[7]   SELECTIVE ELIMINATION OF IMMUNOLOGICALLY COMPETENT CELLS FROM BONE MARROW AND LYMPHATIC CELL MIXTURES .2. MOUSE SPLEEN CELL FRACTIONATION ON A DISCONTINUOUS ALBUMIN GRADIENT [J].
DICKE, KA ;
VANHOOFT, JI ;
VANBEKKU.DW .
TRANSPLANTATION, 1968, 6 (04) :562-&
[8]   FAILURE OF EARLY ADMINISTRATION OF ANTI-THYMOCYTE GLOBULIN TO LESSEN GRAFT VERSUS HOST-DISEASE IN HUMAN ALLOGENEIC MARROW TRANSPLANT RECIPIENTS [J].
DONEY, KC ;
WEIDEN, PL ;
STORB, R ;
THOMAS, ED .
TRANSPLANTATION, 1981, 31 (02) :141-143
[9]  
FILIPOVICH AH, 1984, LANCET, V1, P469
[10]  
FILIPOVICH AH, 1982, LANCET, V1, P1266
1234567